Psoriasis mainly affects the skin and joints and has serious impacts on the physical,
emotional, and financial life of patients. Recent studies have demonstrated that other …

Evidence that psoriatic disease is burdened by an excess cardiovascular (CV) risk has
accrued, however many questions remain unanswered. Although an interplay between …

Psoriasis is a chronic inflammatory disease of the skin, associated with systemic
inflammation leading to the concept of 'psoriatic march'or 'inflammatory skin march.'In …

Background: Psoriatic arthritis is a chronic inflammatory arthropathy that affects 14%-30% of
patients with skin and/or nail psoriasis, leading to severe physical limitations and disability. It …

Objective We aimed to investigate the effect of targeted therapies on cardiovascular risk in
psoriasis (PsO) and psoriatic arthritis (PsA) via a meta‐analysis of randomized controlled …

Background Major adverse cardiovascular events (MACE) are some of the numerous
comorbidities associated with psoriasis (PsO) and psoriasis arthritis (PsA). Previous studies …

One of the most clinically important aspects of recent advances in our understanding of
psoriasis has been the detection of an association between this disease and an increased …

Introduction There is compelling evidence about the independent association between
psoriasis and an increased risk of cardiovascular diseases, in particular myocardial …

Background: Psoriasis (Pso) is a chronic, recurrent, and inflammatory disease involving
genetic and immune factors. Psoriatic arthritis (PsA), accounting for 30% of Pso, is an …

Background: Whether systemic treatments for psoriasis or psoriatic arthritis affect
cardiovascular comorbidities is a clinically significant question. Objective: To examine the …